unknown
Stage
About
Alexza Pharmaceuticals developed inhalation-based drug delivery technologies (notably the Staccato system) and commercialized therapeutics such as Adasuve, an inhaled treatment for acute agitation in schizophrenia and bipolar disorder. The company focused on rapid systemic delivery of medications via inhalation.
Explore Alexza Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.